PHT Corporation Achieves Strong Growth In 3rd Quarter As Demand For Patient-Driven eData Systems In Clinical Research Grows
PHT Corporation third-quarter bookings climbed sharply, 97% over the same period in 2013 as more trial sponsors and CROs adopted its eCOA Systems to collect patient-driven eData for clinical research programs.
The PHT eCOA System was chosen by 12 different pharmaceutical and biotech clients to collect patient-driven eData for 20 clinical research programs in 11 therapeutic areas. PHT is seeing strong demand for eCOA Systems across therapeutic areas with adoption increasing greatly in oncology, immunology and endocrinology indications along with respiratory and neurology. Sales were both direct to customer and through CRO partnerships.
Help employers find you! Check out all the jobs and post your resume.
The PHT eCOA System was chosen by 12 different pharmaceutical and biotech clients to collect patient-driven eData for 20 clinical research programs in 11 therapeutic areas. PHT is seeing strong demand for eCOA Systems across therapeutic areas with adoption increasing greatly in oncology, immunology and endocrinology indications along with respiratory and neurology. Sales were both direct to customer and through CRO partnerships.
Help employers find you! Check out all the jobs and post your resume.